Clinical Trial, Phase I

Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study

Vol. 91 No. 2 (2006): February, 2006